Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-92
Closed -$28.8K 90
2024
Q2
$28.8K Sell
92
-131
-59% -$42.3K ﹤0.01% 72
2024
Q1
$70K Hold
223
﹤0.01% 60
2023
Q4
$53K Sell
223
-129
-37% -$28.5K ﹤0.01% 59
2023
Q3
$75K Sell
352
-32
-8% -$6.9K ﹤0.01% 59
2023
Q2
$77K Hold
384
﹤0.01% 52
2023
Q1
$65K Buy
+384
New +$63.9K ﹤0.01% 54

Other funds holding ETN

Antipodes Partners's ETN Position: Q3 2024 in Review

Antipodes Partners sold out of Eaton (ETN) in Q3 2024, closing a stake of 92 shares — an estimated $28.8K sold.

Antipodes Partners first reported a position in ETN in Q1 2023 and held it in 6 quarters. The position peaked at $77K in Q2 2023. 2,123 funds tracked by Wall St. Rank hold ETN as of Q3 2024.

  • Antipodes Partners reported no remaining Eaton position as of Q3 2024 after selling out during the quarter.
  • Antipodes Partners sold 92 Eaton shares in Q3 2024, an estimated $28.8K.
  • Antipodes Partners first reported a position in Eaton in Q1 2023 and held it in 6 quarters.
  • Antipodes Partners's Eaton position peaked at $77K in Q2 2023.
  • 2,123 funds tracked by Wall St. Rank held Eaton as of Q3 2024.

Based on Antipodes Partners's 13F filing for Q3 2024, filed 14 Nov 2024.